Zovighian Bernard J's Form 4 filing
Edwards Lifesciences Corp (EW) · filed Jun 3, 2025
- Accession no.
- 0001225208-25-005684
- Filed
- Jun 3, 2025
- Trade date
- May 30-Jun 3, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $1.32M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Zovighian Bernard JCIK 0001665141 | Director, Officer (CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 30, 2025 | Common Stock | SSaleDisposed | −16,099 | $77.21 | −$1,243,003.79 | 9,563.55 | Indirect | |
| Jun 3, 2025 | Common Stock | SSaleDisposed | −967 | $77.32 | −$74,768.44 | 8,596.55 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.